For people who are seriously ill and not eligible for a clinical trial, the main pathway to access investigational medicines, Johnson & Johnson Innovative Medicine (J&J IM) accepts requests for our investigational medicines from their treating physicians. Below are the number of patients to whom J&J IM has provided pre-approval access (PAA) annually since 2015:
Year |
Number of requests approved |
|---|---|
2015 |
175 |
2016 |
1,901 |
2017 |
1,111 |
2018 |
726 |
2019 |
469 |
2020 |
552 |
2021 |
991 |
2022 |
1,539 |
2023 |
1,781 |
2024 |
637 |
Total |
9,882 |
For more information about PAA at J&J Innovative Medicine, please click here.